Anixa Biosciences Total Liabilities

Anixa Biosciences (ANIX) currently reports a total liabilities of $1.6M as of April 2026. That compares with $2.1M in the prior-year period — down 20.8% year over year. Use the charts on this page to explore Anixa Biosciences's total liabilities history and peer comparisons.

Anixa Biosciences's total liabilities decreased from $2.1M to $1.6M — a 20.8% year-over-year decrease (period ending April 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Anixa Biosciences reported $1.6M in total liabilities as of April 2026. That compares with $2.1M in the prior-year period — down 20.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $1.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Anixa Biosciences, and consider following ANIX for alerts when major investors trade the stock.

Anixa Biosciences is classified in the Technology sector. On total liabilities, it currently shows $1.6M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing ANIX with unrelated industries.